EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 9

Quercetin

Also called: quercetin aglycone

Quercetin is a flavonoid (a flavonol) found in many foods and herbs, including onions, apples, berries, tea and red wine, and is a regular part of a normal diet. Supplements typically provide 500 to 1000 mg daily.

Category
Other
Forms
Quercetin (aglycone) supplements; quercetin glycosides such as quercetin glucosides and rutin occur in foods
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2016 meta-analysis pooled 7 placebo-controlled RCTs (9 treatment arms, 587 patients) of oral quercetin (100 to 1000 mg/day) on blood pressure; six gave quercetin and one a quercetin-rich supplement. [2]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Quercetin does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Quercetin, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood pressureBA 2016 meta-analysis of placebo-controlled RCTs (7 trials, 9 arms, 587 patients) found quercetin lowered systolic BP by 3.04 and diastolic by 2.63 mmHg; significant effects appeared at doses of 500 mg/day or more. [2]
Blood lipidsXA meta-analysis of five RCTs (442 subjects) found no clinically relevant effect of quercetin on LDL, HDL or total cholesterol; triglycerides fell only in a higher-dose, longer-duration subgroup. [4]
Endurance exercise capacityBA 2011 meta-analysis of 11 studies (254 subjects; median 1000 mg/day for 11 days) found a statistically significant but trivial-to-small benefit (about 2%) over placebo on VO2max and endurance performance. [5]

Main constituents: Quercetin, the most abundant dietary flavonol [2]; Food forms include quercetin glucosides (onions) and quercetin rutinoside (rutin, the major quercetin compound in tea) [3]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Blood-pressure trials: reductions were significant at doses of 500 mg/day or more and not significant below 500 mg/day. [2]
  • Endurance-exercise studies: median dosage 1000 mg/day, median treatment duration 11 days. [5]
  • LiverTox: supplements are typically taken in doses of 500 to 1000 mg daily; typical Western dietary intake is estimated at 4 to 40 mg daily. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated March 28, 2020).

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    5 listed

    Drugs metabolized by CYP3A4 or CYP2C19; Warfarin; Losartan; Tamoxifen; Chemotherapy drugs

    Details and sources
  • Cancer evaluations (IARC, NTP)
    2 found

    Each names the exact material tested, which may differ from a supplement.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • LiverTox: quercetin supplements have not been linked to serum aminotransferase elevations, and there have been no published reports of clinically apparent liver injury attributable to quercetin (likelihood score E, unlikely cause). [1]
  • MSK: because of its antioxidant effects, quercetin may interfere with the actions of certain chemotherapy drugs. [6]
Interactions

Interactions

Quercetin
From the table below 4 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Quercetin
WithWhat happens
Drugs metabolized by CYP3A4 or CYP2C19MSK: quercetin significantly inhibited constitutive CYP3A4 and CYP2C19 activity in vitro; clinical relevance is not known. MSK lists these substrates under 'Do not take if'. [6]
WarfarinMSK cites a patient who presented with an elevated INR following quercetin supplementation; the INR normalized after quercetin was stopped. [6]
LosartanMSK: quercetin increased systemic exposure to losartan in a murine model; clinical significance is not known. [6]
TamoxifenMSK: quercetin significantly increased the bioavailability of tamoxifen in preclinical studies; clinical relevance has yet to be determined. [6]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Regulation

Regulatory status

  • US: FDA had no questions about GRAS Notice 341 for quercetin as an ingredient in beverages, grain products and pastas, processed fruits and fruit juices, and soft candies at up to 500 mg per serving (closed November 22, 2010); FDA noted some uses may require a color additive listing. [7]
  • US: No NDI notification naming quercetin was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29); one entry (NDI 105, submitted 2000-12-28) names isoquercetin. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [8]
  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; a firm is responsible for ensuring its products are not adulterated. [9]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Quercetin, the most abundant dietary flavonol Flavonoids (flavonol) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming quercetin was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29); one entry (NDI 105, submitted 2000-12-28) names isoquercetin. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
  • FDA had no questions about GRAS Notice 341 for quercetin as an ingredient in beverages, grain products and pastas, processed fruits and fruit juices, and soft candies at up to 500 mg per serving (closed November 22, 2010); FDA noted some uses may require a color additive listing. [P3]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • IARC: quercetin is classified in Group 3 (IARC Monographs Supplement 7 and Volume 73; listed year 1999). [P4]
  • NTP TR-409 (quercetin in feed at 1,000, 10,000 or 40,000 ppm for 2 years, F344/N rats): some evidence of carcinogenic activity in male rats, based on increased renal tubule cell adenomas; no evidence in female rats. [P5]

Liver (NIH LiverTox)

  • LiverTox likelihood score E: unlikely cause of clinically apparent liver injury (chapter last updated March 28, 2020). [P6]

Interactions with medicines

  • Drugs metabolized by CYP3A4 or CYP2C19: MSK: quercetin significantly inhibited constitutive CYP3A4 and CYP2C19 activity in vitro; clinical relevance is not known. MSK lists these substrates under 'Do not take if'. [P7]
  • Warfarin: MSK cites a patient who presented with an elevated INR following quercetin supplementation; the INR normalized after quercetin was stopped. [P7]
  • Losartan: MSK: quercetin increased systemic exposure to losartan in a murine model; clinical significance is not known. [P7]
  • Tamoxifen: MSK: quercetin significantly increased the bioavailability of tamoxifen in preclinical studies; clinical relevance has yet to be determined. [P7]
  • Chemotherapy drugs: MSK: because of its antioxidant effects, quercetin may interfere with the actions of certain chemotherapy drugs. [P7]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P8]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • In nine healthy ileostomy subjects, absorption was 52 ± 15% for quercetin glucosides from onions, 17 ± 15% for quercetin rutinoside and 24 ± 9% for quercetin aglycone (100 mg). [P9]
  • In 12 healthy volunteers, only quercetin glucuronides (no free quercetin) were detected in plasma; terminal elimination half-life was about 11 hours for all forms tested. [P10]

Formulations studied to change absorption

Human data only.

  • Form matters: quercetin-4'-O-glucoside and an onion supplement (both 100 mg quercetin equivalents) gave peak plasma levels of 2.1 and 2.3 µg/mL at about 0.7 h, versus 0.3 µg/mL at 7.0 h for rutin (200 mg equivalents). [P10]

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Serban MC, et al. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016;5(7):e002713 (PMID 27405810), 2016-07-12. pubmed.ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. U.S. FDA. GRAS Notice Inventory: GRN No. 341, Quercetin (closed November 22, 2010), 2010-11-22. hfpappexternal.fda.gov
  4. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  5. National Toxicology Program. TR-409: Toxicology and Carcinogenesis Studies of Quercetin (CASRN 117-39-5) in F344 Rats (Feed Studies) (September 1992), 1992-09. ntp.niehs.nih.gov
  6. LiverTox (NIDDK, NCBI Bookshelf NBK556474). Quercetin (Last Update March 28, 2020), 2020-03-28. ncbi.nlm.nih.gov
  7. Memorial Sloan Kettering Cancer Center. About Herbs: Quercetin (Last Updated October 10, 2023), 2023-10-10. mskcc.org
  8. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  9. Hollman PC, et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62(6):1276-82 (PMID 7491892), 1995-12. pubmed.ncbi.nlm.nih.gov
  10. Graefe EU, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 2001;41(5):492-9 (PMID 11361045), 2001-05. pubmed.ncbi.nlm.nih.gov
Sources

Sources

  1. LiverTox (NIDDK, NCBI Bookshelf NBK556474). Quercetin (Last Update March 28, 2020), 2020-03-28. ncbi.nlm.nih.gov
  2. Serban MC, et al. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016;5(7):e002713 (PMID 27405810), 2016-07-12. pubmed.ncbi.nlm.nih.gov
  3. Hollman PC, et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62(6):1276-82 (PMID 7491892), 1995-12. pubmed.ncbi.nlm.nih.gov
  4. Sahebkar A. Effects of quercetin supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2017;57(4):666-676 (PMID 25897620), 2017-03-04. pubmed.ncbi.nlm.nih.gov
  5. Kressler J, et al. Quercetin and endurance exercise capacity: a systematic review and meta-analysis. Med Sci Sports Exerc 2011;43(12):2396-404 (PMID 21606866), 2011-12. pubmed.ncbi.nlm.nih.gov
  6. Memorial Sloan Kettering Cancer Center. About Herbs: Quercetin (Last Updated October 10, 2023), 2023-10-10. mskcc.org
  7. U.S. FDA. GRAS Notice Inventory: GRN No. 341, Quercetin (closed November 22, 2010), 2010-11-22. hfpappexternal.fda.gov
  8. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  9. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.